Furopyridines as inhibitors of protein kinases
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14310%2F20%3A00116541" target="_blank" >RIV/00216224:14310/20:00116541 - isvavai.cz</a>
Result on the web
<a href="https://worldwide.espacenet.com/patent/search/family/050679866/publication/EP2940022B1?q=pn%3DEP2940022B1" target="_blank" >https://worldwide.espacenet.com/patent/search/family/050679866/publication/EP2940022B1?q=pn%3DEP2940022B1</a>
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Furopyridines as inhibitors of protein kinases
Original language description
The invention relates to furo[3,2- b ]pyridines substituted at least in position 5 as inhibitors of protein kinases, regulators or modulators, methods of preparation thereof, pharmaceutical compositions containing the compounds, and pharmaceutical use of the compounds and compositions in the treatment of the diseases such as, for example, cancer or neurodegenerative diseases.
Czech name
—
Czech description
—
Classification
Type
P - Patent
CEP classification
—
OECD FORD branch
10401 - Organic chemistry
Result continuities
Project
<a href="/en/project/LM2015063" target="_blank" >LM2015063: National Infrastructure for Chemical Biology</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)<br>S - Specificky vyzkum na vysokych skolach
Others
Publication year
2020
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Patent/design ID
EP2940022
Publisher
EPO_1 -
Publisher name
European Patent Office
Place of publication
Munich, The Hague, Berlin, Vienna, Brussels
Publication country
—
Date of acceptance
Sep 2, 2020
Owner name
Masarykova univerzita
Method of use
A - Výsledek využívá pouze poskytovatel
Usage type
A - K využití výsledku jiným subjektem je vždy nutné nabytí licence